ribociclib
eli lilly,novartis
['kisqali', 'breast', 'novartis', ' lilly']
asco: novartis pressures lilly with kisqali, targeting $3b opportunity in early breast cancer 
Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.